International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY)

儿童、青少年和年轻成人癌症幸存者后续结直肠癌的国际研究 (I-SCRY)

基本信息

  • 批准号:
    10569105
  • 负责人:
  • 金额:
    $ 35.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-08 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Survivors of childhood, adolescent, and young adult (AYA) cancer have an elevated risk of subsequent malignant neoplasms which are associated with morbidity and premature mortality. Emerging evidence suggests that colorectal cancer (CRC), associated with abdominal or pelvic radiotherapy used to treat the childhood or AYA cancer, is one such neoplasm. Early studies indicate other treatment exposures, including cisplatin and alkylator therapy, may also be associated with CRC risk and may interact with the radiotherapy to confer a markedly elevated risk. Knowledge of whether age at exposure to these therapies might modify risk is limited. Further, prognosis after a treatment-related CRC is not well-understood. These gaps in knowledge are due to the limited number of CRCs in any single cohort, lack of detailed information on primary cancer treatments for some cohorts, the relatively young age of cohorts, and the focus of existing cohorts on either childhood cancer survivors or on survivors of specific young adult cancers. We propose to leverage the unique resources of eight international childhood and AYA cancer survivor cohorts. We will pool individual participant data on 51,309 survivors, 298 with CRC, and with median follow-up across studies ranging from 13 to 26 years after primary cancer diagnosis, to comprehensively examine risk factors of, and mortality after, subsequent CRCs. This is almost four-fold the number of CRCs in any known childhood or AYA cohort with detailed treatment data available. Thus, the combination of childhood and AYA cancer survivors into a single cohort is novel and given common treatment approaches to pediatric and AYA cancer, will enable us to address these questions with the ability to assess the role of age at exposure. The primary aim of this project is to evaluate the association of childhood and AYA cancer therapy (abdominal and/or pelvic radiation fields and dose, as well as chemotherapy exposures including cumulative doses of alkylating agents, anthracyclines, platinating agents) on CRC risk in a large, multi-cohort, international survivor population. Secondary aims will focus on conducting an expanded assessment of the burden of CRC in childhood and AYA cancer survivors. This includes estimating and comparing the incidence of CRC in childhood and AYA cancer survivors to the incidence of CRC in the general population, as well as characterizing mortality following a CRC diagnosis in childhood and AYA cancer survivors and comparing it to that observed following a de novo CRC diagnosis in the general population. The results from this work have the potential to help refine screening guidelines and strategies for preventing CRC. In addition, in achieving our aims, we will establish a resource that may be leveraged for future investigator-initiated research.
项目总结/摘要 儿童、青少年和年轻成人(AYA)癌症的幸存者, 与发病率和过早死亡率相关的恶性肿瘤。新出现的证据 提示结直肠癌(CRC),与腹部或盆腔放疗用于治疗 儿童癌症或AYA癌症就是这样的肿瘤之一。早期的研究表明,其他治疗暴露,包括 顺铂和烷化剂治疗也可能与CRC风险相关,并可能与放疗相互作用, 会带来明显的高风险关于暴露于这些治疗的年龄是否可能改变风险的知识是 有限公司此外,治疗相关CRC后的预后尚不清楚。这些知识差距是 由于任何单一队列中CRC数量有限,缺乏原发性癌症的详细信息 一些队列的治疗,队列相对年轻的年龄,以及现有队列的重点是 儿童癌症幸存者或特定的年轻成人癌症幸存者。 我们建议利用八个国际儿童和AYA癌症幸存者的独特资源, 同伙我们将汇总51,309名幸存者的个体参与者数据,其中298名患有CRC,并进行中位随访 在原发性癌症诊断后13至26年的研究中, 随后的CRC的因素和死亡率。这几乎是任何已知国家CRC数量的四倍。 有详细治疗数据的儿童或AYA队列。因此,童年和AYA的结合 将癌症幸存者纳入单一队列是新颖的,并给予儿科和AYA常见的治疗方法。 癌症,将使我们能够解决这些问题的能力,以评估年龄在暴露的作用。 该项目的主要目的是评估儿童和AYA癌症治疗的相关性 (腹部和/或盆腔辐射野和剂量,以及化疗暴露,包括累积 剂量的烷化剂、蒽环类、铂类药物)对CRC风险的影响。 幸存人口。次要目标将侧重于对CRC负担进行扩大评估 在儿童和癌症幸存者中。这包括估计和比较结直肠癌的发病率, 儿童和AYA癌症幸存者与一般人群中CRC发病率的关系,以及 描述儿童和AYA癌症幸存者中CRC诊断后的死亡率,并将其与 这是在一般人群中新发CRC诊断后观察到的。 这项工作的结果有可能帮助完善筛查指南和策略, 预防CRC。此外,为了实现我们的目标,我们将建立一种资源, 未来的研究方向。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tara Olive Henderson其他文献

Tara Olive Henderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tara Olive Henderson', 18)}}的其他基金

International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY)
儿童、青少年和年轻成人癌症幸存者后续结直肠癌的国际研究 (I-SCRY)
  • 批准号:
    10375018
  • 财政年份:
    2022
  • 资助金额:
    $ 35.44万
  • 项目类别:
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
ASPIRES 研究:激活癌症幸存者及其初级保健提供者以加强结直肠癌筛查
  • 批准号:
    10096080
  • 财政年份:
    2021
  • 资助金额:
    $ 35.44万
  • 项目类别:
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
ASPIRES 研究:激活癌症幸存者及其初级保健提供者以加强结直肠癌筛查
  • 批准号:
    10327669
  • 财政年份:
    2021
  • 资助金额:
    $ 35.44万
  • 项目类别:
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
ASPIRES 研究:激活癌症幸存者及其初级保健提供者以加强结直肠癌筛查
  • 批准号:
    10582711
  • 财政年份:
    2021
  • 资助金额:
    $ 35.44万
  • 项目类别:
Health Beliefs and Behavior: Cohort Studies in Pediatric Cancer Survivorship
健康信念和行为:儿科癌症幸存者的队列研究
  • 批准号:
    7922034
  • 财政年份:
    2008
  • 资助金额:
    $ 35.44万
  • 项目类别:
Health Beliefs and Behavior: Cohort Studies in Pediatric Cancer Survivorship
健康信念和行为:儿科癌症幸存者的队列研究
  • 批准号:
    7688047
  • 财政年份:
    2008
  • 资助金额:
    $ 35.44万
  • 项目类别:
Health Beliefs and Behavior: Cohort Studies in Pediatric Cancer Survivorship
健康信念和行为:儿科癌症幸存者的队列研究
  • 批准号:
    7513646
  • 财政年份:
    2008
  • 资助金额:
    $ 35.44万
  • 项目类别:
Health Beliefs and Behavior: Cohort Studies in Pediatric Cancer Survivorship
健康信念和行为:儿科癌症幸存者的队列研究
  • 批准号:
    8129819
  • 财政年份:
    2008
  • 资助金额:
    $ 35.44万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10162528
  • 财政年份:
    1997
  • 资助金额:
    $ 35.44万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10379991
  • 财政年份:
    1997
  • 资助金额:
    $ 35.44万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了